Media coverage
7
Media coverage
Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder Media name/outlet Morningstar.com Country/Territory United States Date 16/09/24 URL https://www.morningstar.com/news/business-wire/20240916829229/autobahn-therapeutics-announces-initiation-of-its-amplify-phase-2-trial-of-abx-002-as-an-adjunctive-treatment-for-major-depressive-disorder Persons Dan Vlad Iosifescu Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder Media name/outlet Business Wire Country/Territory United States Date 16/09/24 URL www.businesswire.com/news/home/20240916829229/en/Autobahn-Therapeutics-Announces-Initiation-of-its-AMPLIFY-Phase-2-Trial-of-ABX-002-as-an-Adjunctive-Treatment-for-Major-Depressive-Disorder/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw== Persons Dan Vlad Iosifescu Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder; AMPLIFY 230-patient trial aims to improve on efficacy and safety established with thyroid hormone as an adjunctive Media name/outlet Business Wire Country/Territory United States Date 16/09/24 Persons Dan Vlad Iosifescu Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder Media name/outlet Yahoo! Finance Country/Territory United States Date 16/09/24 URL https://finance.yahoo.com/news/autobahn-therapeutics-announces-initiation-amplify-120000090.html Persons Dan Vlad Iosifescu Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder Media name/outlet APNews.com Country/Territory United States Date 16/09/24 URL https://apnews.com/press-release/business-wire/depression-medication-0c3cf1061a184572866ca19b7e18a917 Persons Dan Vlad Iosifescu Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder Media name/outlet Le Lezard.com Country/Territory Canada Date 16/09/24 URL https://www.lelezard.com/en/news-21525163.html Persons Dan Vlad Iosifescu Title Autobahn Therapeutics Announces Initiation of its AMPLIFY Phase 2 Trial of ABX-002 as an Adjunctive Treatment for Major Depressive Disorder Media name/outlet BioSpace Country/Territory United States Date 16/09/24 URL https://www.biospace.com/press-releases/autobahn-therapeutics-announces-initiation-of-its-amplify-phase-2-trial-of-abx-002-as-an-adjunctive-treatment-for-major-depressive-disorder Persons Dan Vlad Iosifescu